Vascular Endothelial Growth Factor Gene Polymorphism (rs2010963) and Its Receptor, Kinase Insert Domain-Containing Receptor Gene Polymorphism (rs2071559), and Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus

Journal of Diabetes Research
Sebastjan MerloDaniel Petrovič

Abstract

Background. The current study was designed to reveal possible associations between the polymorphisms of the vascular endothelial growth factor (VEGF) gene (rs2010963) and its receptor, kinase insert domain-containing receptor (KDR) gene polymorphism (rs2071559), and markers of carotid atherosclerosis in patients with type 2 diabetes mellitus (T2DM). Patients and Methods. 595 T2DM subjects and 200 control subjects were enrolled. The carotid intima-media thickness (CIMT) and plaque characteristics (presence and structure) were assessed ultrasonographically. Biochemical analyses were performed using standard biochemical methods. Genotyping of VEGF/KDR polymorphisms (rs2010963, rs2071559) was performed using KASPar assays. Results. Genotype distributions and allele frequencies of the VEGF/KDR polymorphisms (rs2010963, rs2071559) were not statistically significantly different between diabetic patients and controls. In our study, we demonstrated an association between the rs2071559 of KDR and either CIMT or the sum of plaque thickness in subjects with T2DM. We did not, however, demonstrate any association between the tested polymorphism of VEGF (rs2010963) and either CIMT, the sum of plaque thickness, the number of involved segments,...Continue Reading

References

Dec 21, 2004·Journal of the American College of Cardiology·Pedro R Moreno, Valentin Fuster
Sep 1, 2006·Current Opinion in Critical Care·Natalie Khuseyinova, Wolfgang Koenig
Nov 10, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Marcella van LeeuwenJan Willem Cohen Tervaert
Mar 18, 2008·The British Journal of Surgery·D A RussellM J Gough
Dec 18, 2008·Scandinavian Journal of Clinical and Laboratory Investigation·Tiia Kangas-KontioSakari Kakko
Mar 11, 2011·Tissue Antigens·L Rodríguez-RodríguezM A González-Gay
Jul 5, 2013·The Journal of Experimental Medicine·Attila Mócsai
Aug 1, 2013·Physiological Reviews·Paul N Hopkins
Mar 26, 2014·Nature Reviews. Endocrinology·Markku Laakso, Johanna Kuusisto

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
Assay
ELISA

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.